Website review pharmaphorum.com
pharmaphorum | News & views on pharma and biotech’s evolving future
Generated on March 06 2026 13:56 PM
Old data? UPDATE !
The score is 56/100
SEO Content
Title
pharmaphorum | News & views on pharma and biotech’s evolving future
Length : 67
Perfect, your title contains between 10 and 70 characters.
Description
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Length : 158
Great, your meta description contains between 70 and 160 characters.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| site_name | pharmaphorum |
| url | https://pharmaphorum.com/homepage |
| title | pharmaphorum| News & views on pharma and biotech’s evolving future |
| description | Pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future. |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 7 | 37 | 0 | 12 | 0 |
- [H2] Featured Content
- [H2] Latest News
- [H2] Views & Analysis
- [H2] Deep Dive
- [H2] White Papers & Webinar
- [H2] Podcasts & Video
- [H2] Partner Content
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] The GLP-1 Reckoning
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] What US healthcare companies and medical researchers need to...
- [H3] What US healthcare companies and medical researchers need to...
- [H3] The GLP-1 Reckoning
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] New hope for ovarian cancer, with Alexander Schneider
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] Editor's Picks
- [H3] China's clears Pfizer GLP-1 ecnoglutide for weight loss
- [H3] J&J's Tecvayli claims third national priority FDA approval
- [H3] Alnylam bets on Tenaya RNAi tech, and other licensing news
- [H3] Lilly unveils employer scheme for weight-loss drug Zepbound
- [H3] What US healthcare companies and medical researchers need to...
- [H3] JPM 2026: What it revealed about biotech’s new reality
- [H3] Pharma’s search loophole is a preview of what comes next
- [H3] Legacy data into living scientific memory
- [H3] The GLP-1 Reckoning
- [H3] GLP-1s: Five years that changed metabolic medicine
- [H3] Redesigning obesity trials for a chronic disease era
- [H3] The trust gap: GLP-1s and the new information economy of obe...
- [H3] Using AI-driven synthetic personas to take your insights fur...
- [H3] Expert Directed Applied Intelligence: Redefining AI in Life ...
- [H3] The strategic imperative of Integrated Evidence Generation P...
- [H3] Data managers and CRAs warn of rising data quality risks due...
- [H3] AI in clinical development & ‘white space’, with Andrew Mack...
- [H3] Collaboration & personalisation in rare disease R&D, with AO...
- [H3] Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...
- [H3] On JPM2026 and healthcare investment today, with Jonah Comst...
- [H3] 7th Dermatology Drug Development Summit Europe
- [H3] The PM Society Launches Pharmony to Support More Effective P...
- [H3] EVERSANA Names Monica Avram Executive Vice President and Chi...
- [H3] Emerging Trends in Personalised Medicine at PHARMAP 2026
- [H3] Book your tickets and join the PM Society for the 40th PM Aw...
- [H5] header links
- [H5] Pharmaphorum menu first category
- [H5] SECTION
- [H5] Channels
- [H5] Channels
- [H5] SUB NAVIGATION
- [H5] US lawmakers take FDA to task over rare diseases record
- [H5] Gilead buys cell therapy partner Arcellx for up to $7.8bn
- [H5] What next for pharma as SCOTUS strikes down Trump tariffs?
- [H5] Novo Nordisk to cut GLP-1 prices in tough US market
- [H5] UK spurs prescribing of obesity jab Mounjaro with GP bonus
- [H5] Pharmaphorum Menu
Images
We found 42 images on this web page.
Good, most or all of your images have alt attributes.
Text/HTML Ratio
Ratio : 18%
Good, this page's ratio of text to HTML code is higher than 15, but lower than 25 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.
In-page links
We found a total of 136 links including 1 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Skip to main content | Internal | Passing Juice |
| BlueSky | External | Passing Juice |
| External | Passing Juice | |
| youtube | External | Passing Juice |
| Get Newsletters | Internal | Passing Juice |
| Media Kit | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Equity and Sustainability | Internal | Passing Juice |
| Research & Development | Internal | Passing Juice |
| Market Access | Internal | Passing Juice |
| Oncology | Internal | Passing Juice |
| Artificial Intelligence | Internal | Passing Juice |
| Patients & Partnerships | Internal | Passing Juice |
| GLP-1 | Internal | Passing Juice |
| Previous Editions | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Videos | Internal | Passing Juice |
| Spotlight on | Internal | Passing Juice |
| ASCO 2025 | Internal | Passing Juice |
| BIO 2025 | Internal | Passing Juice |
| C-Suite Innovators | Internal | Passing Juice |
| ESMO 2025 | Internal | Passing Juice |
| Frontiers Health 2025 | Internal | Passing Juice |
| JP Morgan | Internal | Passing Juice |
| Global Policy Insights | Internal | Passing Juice |
| Events | Internal | Passing Juice |
| close | External | Passing Juice |
| Market Access | Internal | Passing Juice |
| Oncology | Internal | Passing Juice |
| Patients & Partnerships | Internal | Passing Juice |
| Commercialisation | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Sales & Marketing | Internal | Passing Juice |
| R&D | Internal | Passing Juice |
| Digital | Internal | Passing Juice |
| Market Access | Internal | Passing Juice |
| Oncology | Internal | Passing Juice |
| Patients | Internal | Passing Juice |
| Live Coverage | Internal | Passing Juice |
| Partner Content | Internal | Passing Juice |
| About us | Internal | Passing Juice |
| Contribute | Internal | Passing Juice |
| Contact us | Internal | Passing Juice |
| Sign in | Internal | Passing Juice |
| China's clears Pfizer GLP-1 ecnoglutide for weight loss | Internal | Passing Juice |
| J&J's Tecvayli claims third national priority FDA approval | Internal | Passing Juice |
| The GLP-1 Reckoning | Internal | Passing Juice |
| Alnylam bets on Tenaya RNAi tech, and other licensing news | Internal | Passing Juice |
| What US healthcare companies and medical researchers need to... | Internal | Passing Juice |
| Using AI-driven synthetic personas to take your insights fur... | Internal | Passing Juice |
| AI in clinical development & ‘white space’, with Andrew Mack... | Internal | Passing Juice |
| New hope for ovarian cancer, with Alexander Schneider | Internal | Passing Juice |
| Expert Directed Applied Intelligence: Redefining AI in Life ... | Internal | Passing Juice |
| US lawmakers take FDA to task over rare diseases record | Internal | Passing Juice |
| Gilead buys cell therapy partner Arcellx for up to $7.8bn | Internal | Passing Juice |
| What next for pharma as SCOTUS strikes down Trump tariffs? | Internal | Passing Juice |
| Novo Nordisk to cut GLP-1 prices in tough US market | Internal | Passing Juice |
| UK spurs prescribing of obesity jab Mounjaro with GP bonus | Internal | Passing Juice |
| Subscribe | Internal | Passing Juice |
| Lilly unveils employer scheme for weight-loss drug Zepbound | Internal | Passing Juice |
| JPM 2026: What it revealed about biotech’s new reality | Internal | Passing Juice |
| Pharma’s search loophole is a preview of what comes next | Internal | Passing Juice |
| Legacy data into living scientific memory | Internal | Passing Juice |
| GLP-1s: Five years that changed metabolic medicine | Internal | Passing Juice |
| Redesigning obesity trials for a chronic disease era | Internal | Passing Juice |
| The trust gap: GLP-1s and the new information economy of obe... | Internal | Passing Juice |
| The strategic imperative of Integrated Evidence Generation P... | Internal | Passing Juice |
| Data managers and CRAs warn of rising data quality risks due... | Internal | Passing Juice |
| Collaboration & personalisation in rare disease R&D, with AO... | Internal | Passing Juice |
| Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al... | Internal | Passing Juice |
| On JPM2026 and healthcare investment today, with Jonah Comst... | Internal | Passing Juice |
| 7th Dermatology Drug Development Summit Europe | Internal | Passing Juice |
| The PM Society Launches Pharmony to Support More Effective P... | Internal | Passing Juice |
| EVERSANA Names Monica Avram Executive Vice President and Chi... | Internal | Passing Juice |
| Emerging Trends in Personalised Medicine at PHARMAP 2026 | Internal | Passing Juice |
| Book your tickets and join the PM Society for the 40th PM Aw... | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Views & Analysis | Internal | Passing Juice |
| Deep Dive | Internal | Passing Juice |
| Webinars | Internal | Passing Juice |
| Podcasts | Internal | Passing Juice |
| Video | Internal | Passing Juice |
| White Papers | Internal | Passing Juice |
| Event | Internal | Passing Juice |
| Axtria Ignite 2025 | Internal | Passing Juice |
| Frontiers Health 2024 | Internal | Passing Juice |
| Life Science Industry Report | Internal | Passing Juice |
| World Without Disease Summit | Internal | Passing Juice |
| Pharmaphorum | Internal | Passing Juice |
| Cookie Policy | Internal | Passing Juice |
| Privacy Policy | Internal | Passing Juice |
| Terms & Conditions | Internal | Passing Juice |
| Work for us | Internal | Passing Juice |
SEO Keywords
Keywords Cloud
healthcare news event digital dive content glp-1 pharmaphorum sponsored white
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| news | 17 |  |
 |
|
|
| white | 11 | |
|
|
|
| event | 10 | |
|
|
|
| healthcare | 9 | |
|
|
|
| content | 9 | |
|
|
|
Usability
Url
Domain : pharmaphorum.com
Length : 16
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Too bad, your website has too many JS files (more than 6). |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://pharmaphorum.com/sitemap.xml |
Robots.txt
https://pharmaphorum.com/robots.txt
Great, your website has a robots.txt file.
Analytics
Great, your website has an analytics tool.
Google Analytics |
PageSpeed Insights
Device
Categories
Free SEO Testing Tool
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.